Sh-Octapeptide-4
A cosmetic ingredient used as anti-seborrheic, antioxidant, chelating in skincare, haircare, and personal-care products sold in the European Union.
What is it?
SH-Octapeptide-4 is a recombinant human peptide produced synthetically to be identical to the protein, Enkephalin. It contains 8 amino acids consisting of glycine, histidine, leucine, lysine, phenylalanine, and tyrosine
What does it do?
Sh-Octapeptide-4 is listed in the EU cosmetic ingredient inventory with the following declared functions:
-
Anti-seborrheic
helps regulate excess sebum production on skin and scalp
-
Antioxidant
neutralises free radicals to slow oxidative damage to the formulation or skin
-
Chelating
binds metal ions to prevent them from interfering with formulation stability
-
Reducing
a reducing agent — donates electrons to break chemical bonds, used in perms and depilatories
-
Skin protecting
helps shield skin from external environmental factors
EU regulatory status
Sh-Octapeptide-4 is allowed for use in cosmetic products in the European Union under Regulation 1223/2009. It is not subject to a specific Annex restriction at the time of writing.
Frequently asked questions
What is Sh-Octapeptide-4?
Sh-Octapeptide-4 is a cosmetic ingredient catalogued in the EU CosIng database. SH-Octapeptide-4 is a recombinant human peptide produced synthetically to be identical to the protein, Enkephalin. It contains 8 amino acids consisting of glycine, histidine, leucine, lysine, phenylalanine, and tyrosine
Is Sh-Octapeptide-4 allowed in cosmetics in the EU?
Yes. Sh-Octapeptide-4 is allowed for use in cosmetic products in the EU under Regulation 1223/2009.
What does Sh-Octapeptide-4 do in cosmetic products?
Sh-Octapeptide-4 is declared in the EU cosmetic ingredient inventory with these functions: anti-seborrheic, antioxidant, chelating, reducing, skin protecting.
What is the CAS number of Sh-Octapeptide-4?
The CAS (Chemical Abstracts Service) number for Sh-Octapeptide-4 is -.
Related ingredients
Source: EU CosIng database (European Commission). This page is derived from public-sector information published by the European Commission. · Last updated: 26/11/2012